2Q EARNINGS: Arena reports first Belviq revenue
This article was originally published in Scrip
Executive Summary
Arena Pharmaceuticals reported its first-ever set of prescription and sales data for the weight loss drug Belviq (lorcaserin) on 1 August and the San Diego-based company revealed plans to study an obesity therapy combination of Belviq with phentermine.